Latest Europe News

Vulcan Energy has won up to €104 million in grants from German federal and state governments to advance its sustainable lithium production project, bolstering Europe’s electric vehicle battery supply chain.

Invex Therapeutics has broadened its collaboration with Tessara Therapeutics to explore Exenatide’s potential in Alzheimer’s disease, while successfully renewing key orphan drug designations in Europe and the US.

Nordic Resources has completed a major acquisition of three advanced gold projects in Finland, lifting its total gold equivalent resources to 1.23 million ounces. The company also secured A$3.5 million in institutional funding and appointed a seasoned mining executive as Chairman.

Green Critical Minerals has commissioned its first VHD Graphite production module and secured $7 million to drive commercialisation, while its McIntosh Project delivers robust economic metrics.

Infinity Lithium progresses its Australian gold-copper-silver exploration with new option agreements, while facing delays and strategic shifts in its Spanish lithium project.

Microba Life Sciences reports strong Q4 FY25 growth driven by record microbiome test sales and clinician adoption in Australia and the UK, while advancing its therapeutics pipeline and targeting regional break-even in FY26.

Genetic Signatures reported steady quarterly sales of $4.4 million, reflecting seasonal demand in Australia, while restructuring its US operations to accelerate growth. A new US contract and strategic partnerships signal potential for future expansion.

Norwood Systems delivered its strongest quarter yet with record cash inflows, significant debt reduction, and expanding global partnerships, setting a robust foundation for FY2026.

Aura Energy has marked significant progress toward uranium production at its Tiris project in Mauritania, while forging a key collaboration to advance uranium exploration in Sweden amid shifting regulatory landscapes.

Yugo Metals Limited has launched a $100,000 capital raising through a new options offer, aiming to bolster working capital while navigating significant geopolitical and operational challenges in Bosnia and Herzegovina.

The Virginia Supreme Court has affirmed the State Corporation Commission’s decision to deny a toll rate increase for the Dulles Greenway, owned by Atlas Arteria. Meanwhile, a related federal case alleging constitutional violations will now proceed.

Little Green Pharma reported a robust June 2025 quarter with record cash receipts and expanding European footprint, highlighted by a new production capacity in Denmark and the launch of its CherryCo brand in Germany.